Irish drug developer signs licensing deal for autoimmune therapies
Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Inflection Biosciences chief Darren Cunningham will be head of Swiss-based Mysthera Therapeutics
Dublin pharma development company’s drug blocks pathways used by cancer cells
Inflection Biosciences working on new way to block spread of cancer cells in patients
Business Today: the best news, analysis and comment from ‘The Irish Times’ business desk
Start-up working on way to block spread of cancer cells in patients with aggressive breast cancer
Inflection Biosciences seeking phase I testing for new therapy targeting aggressive cancer
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices